RE: Insys6 Jul 2016 08:48
"Shares of Insys Therapeutics Inc. INSY, +6.90% soared 19% in premarket trade Tuesday, after the drug maker said the Food and Drug Administration approved its orally administered treatment for anorexia associated with weight loss in AIDS patients, and for nausea associated with chemotherapy. The treatment, Syndros, is a pharmaceutical version of tetrahydrocannabinol, THC, which is the main active ingredient in cannabis. The stock had plunged 53% through Friday, while the S&P 500 has gained 2.9%."
hang on a minute, that stuff is pure synthetic THC, and they are giving it to people to make them feel better, cant be right, THC is the devil incarnate, have the FDA gone mad, have they not heard of sir robin murray and his erm 'groundbreaking studies' that prove THC sends everyone mental and turns them into psychopathic killers??
something is not right here.....')